Related content

Strontium ranelate-induced toxic epidermal necrolysis in a patient with post-menopausal osteoporosis

By Lee H.   Lie D.   Lim K.   Thirumoorthy T.   Pang S.  

Osteoporosis International, Vol. 20, Iss. 1, 2009-01 ,pp. : 161-162

Springer Publishing Company

Access to resources Recommend Favorite

The effect of PTH(1–84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial

By Quesada-Gómez J.   Muschitz C.   Gómez-Reino J.   Greisen H.   Andersen H.   Dimai H.  

Osteoporosis International, Vol. 22, Iss. 9, 2011-09 ,pp. : 2529-2537

Springer Publishing Company

Access to resources Recommend Favorite

Spinal Performance and Functional Impairment in Postmenopausal Women with Osteoporosis and Osteopenia without Vertebral Fracture

By Tsauo J. Y.   Chien M. Y.   Yang R. S.  

Osteoporosis International, Vol. 13, Iss. 6, 2002-06 ,pp. : 456-460

Springer Publishing Company

Access to resources Recommend Favorite

How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis

By Marie P.   Felsenberg D.   Brandi M.  

Osteoporosis International, Vol. 22, Iss. 6, 2011-06 ,pp. : 1659-1667

Springer Publishing Company

Access to resources Recommend Favorite

Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fractures

By Romagnoli Elisabetta   Carnevale Vincenzo   Nofroni Italo   D’Erasmo Emilio   Paglia Federica   Geronimo Simona   Pepe Jessica   Raejntroph Natalia   Maranghi Marianna   Minisola Salvatore  

Osteoporosis International, Vol. 15, Iss. 12, 2004-12 ,pp. : 975-980

Springer Publishing Company

Access to resources Recommend Favorite